Pricing

Intellia Therapeutics

9 followers

‌

Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

201-500

Links

Org chart

John Leonard

President & CEO

Collapse

Eliana Clark

EVP, CTO

David Lebwohl

EVP, Chief Medical Officer

Derek Hicks

EVP, Chief Business Officer

Laura Sepp-Lorenzino

EVP, Chief Scientific Officer

Edward Dulac

EVP & CFO

Marika St. Amand

SVP, Chief Human Resources Officer

James Basta

EVP, General Counsel & Corporate Secretary

Aron Stein

SVP, Regulatory Affairs

Mary Ferguson

Senior Vice President, Head of Intellectual Property

Yuanxin Xu

SVP, Early Development & Transitional Medicine

Maria Natale

SVP, Commercial

Dawn M. Hyde

Executive Assistant

Board & advisors

Founder & Advisor

Founder & Advisor

Founder & Advisor

Founder & Advisor

Founder & Advisor

Founder & Advisor

Founder & Advisor

Board Member

Board Member

Board Member

Board Member

Board Member

Board Member

Board Member

Teams

+29

Research and Development

33 people · 0 jobs

+26

Leadership Team

30 people · 0 jobs

+18

Corporate Governance and Legal

22 people · 0 jobs

Scientific and Technical Positions

10 people · 0 jobs

Clinical Operations

8 people · 0 jobs

Human Resources and Talent Management

6 people · 0 jobs

Offices

HQ
81 positions, 0 job posts
GC
TL
TK
+77

Similar companies

Editas Medicine

5 followers

Arcus Biosciences

3 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

27 followers

Cytiva

15 followers

CRISPR Therapeutics

11 followers

Explore companies